Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation

Medicinal Chemistry Research

Volumn 16, Issue 4, 2007, Pages 179-187

  Ananda Kumar, C S ^a   Nanjunda Swamy, S ^a   Thimmegowda, N R ^a   Benaka Prasad, S B ^a   Yip, George W ^b   Rangappa, K S ^a  

^a UNIVERSITY OF MYSORE   (India)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

1 benzhydryl piperazine derivatives; Cell proliferation; MDA MB 231; Sulfonyl chlorides

Indexed keywords

1 BENZHYDRYL 4 (3,5 DIMETHYL ISOXAZOLE 4 SULFONYL)PIPERAZINE; 1 BENZHYDRYL 4 (4 CHLORO BENZENESULFONYL)PIPERAZINE; 1 BENZHYDRYL 4 (4 TERT BUTYL BENZENESULFONYL)PIPERAZINE; 1 BENZHYDRYL 4 (TOLUENE 4 SULFONYL)PIPERAZINE; 1 BENZHYDRYL 4 METHANESULFONYL PIPERAZINE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 40549101901     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-007-9022-y     Document Type: Article

References (30)

1. M Berkheij 2005 Synthesis of 2-substituted piperazines via direct α-lithation Tetrahedron Lett 15 2369 2371 10.1016/j.tetlet.2005.02.085 1:CAS:528:DC%2BD2MXit1yltbo%3D Berkheij M, et al. (2005) Synthesis of 2-substituted piperazines via direct α-lithation. Tetrahedron Lett 15:2369–2371
2. R Gillet P Jeannesson H Sefraoui ML Arnould-GueArin S Kirkiacharian JC Jardillier F Pieri 1998 Piperazine derivatives of butyric acid as differentiating agents in human leukemic Cells Cancer Chemother Pharmaco 41 252 255 10.1007/s002800050737 1:CAS:528:DyaK1cXls1WjsQ%3D%3D Gillet R, Jeannesson P,Sefraoui H, Arnould-GueArin ML, Kirkiacharian S, Jardillier JC, Pieri F (1998) Piperazine derivatives of butyric acid as differentiating agents in human leukemic Cells. Cancer Chemother Pharmaco 41:252–255
3. FE Gabriel J Gu LM Slater K Hara JW Jacobs 2000 Tumor apoptosis induced by epoxide-containing piperazines: a new class of anti-cancer agents Cancer Chemother Pharmacol 45 183 191 10.1007/s002800050028 Gabriel FE, Gu J, Slater LM, Hara K, Jacobs JW (2000) Tumor apoptosis induced by epoxide-containing piperazines: a new class of anti-cancer agents. Cancer Chemother Pharmacol 45:183–191
4. C Hulme 1999 Novel applications of ethylgyyoxalate with the Ugi MCR Tetrahedron Lett 40 5295 10.1016/S0040-4039(99)00960-0 1:CAS:528:DyaK1MXksVyntr0%3D Hulme C, et al. (1999) Novel applications of ethylgyyoxalate with the Ugi MCR. Tetrahedron Lett 40:5295
5. RS Upadhayaya N Sinha S Jain N Kishore R Chandra SK Arora 2004 Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-{2-[4-aryl-piperazin-1-yl]-ethyl}-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol Bioorg Med Chem 12 2225 15080922 10.1016/j.bmc.2004.02.014 1:CAS:528:DC%2BD2cXjtVKqu74%3D Upadhayaya RS, Sinha N, Jain S, Kishore N, Chandra R, Arora SK (2004) Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-{2-[4-aryl-piperazin-1-yl]-ethyl}-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol. Bioorg Med Chem 12:2225
6. P Choudhary R Kumar K Verma 2006 Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives Bioorg Med Chem 14 1819 1826 10.1016/j.bmc.2005.10.032 1:CAS:528:DC%2BD28XhtlKlsr4%3D Choudhary P, Kumar R, Verma K (2006) Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives. Bioorg Med Chem 14:1819–1826
7. JP Vacca 1994 The design of a potent and orally bioavailable HIV protease inhibotor J Med Chem 37 3443 7932573 10.1021/jm00047a001 Vacca JP, et al. (1994) The design of a potent and orally bioavailable HIV protease inhibotor. J Med Chem 37:3443
8. D Askin 1994 Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524 Tetrahedron Lett 35 673 10.1016/S0040-4039(00)75787-X 1:CAS:528:DyaK2cXmsFKhtLc%3D Askin D, et al. (1994) Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524. Tetrahedron Lett 35:673
9. K Rossen 1995 Asymmetric hydrogenation of tetrahydropyrazines: Synthesis of (S)-piperazine-2-tert-butylcarboxamide, an intermediate in the preparation of the HIV protease inhibitor indinavir Tetrahedron Lett 36 6419 10.1016/0040-4039(95)01345-I 1:CAS:528:DyaK2MXnvFCls74%3D Rossen K, et al. (1995) Asymmetric hydrogenation of tetrahydropyrazines: Synthesis of (S)-piperazine-2-tert-butylcarboxamide, an intermediate in the preparation of the HIV protease inhibitor indinavir. Tetrahedron Lett 36:6419
10. EGYT (1975) Pyridine derivatives having antidepressant activity. US-3865828
11. M Yoshida Y Maehara K Sugimachi 1999 MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy Clinical Cancer Research 5 4295 4300 10632373 1:CAS:528:DC%2BD3cXlsV2msQ%3D%3D Yoshida M, Maehara Y,Sugimachi K (1999) MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy. Clinical Cancer Research 5:4295–4300
12. A Mark 2004 Synthesis and functional activity of (2-aryl-1-piperizinyl)-N-(3-methylphenyl) acetamides: selective dopamine D 4 receptor agonists Bioorg Med Chem 12 3471 3483 10.1016/j.bmc.2004.04.035 1:CAS:528:DC%2BD2cXks12ktLY%3D Mark A, et al. (2004) Synthesis and functional activity of (2-aryl-1-piperizinyl)-N-(3-methylphenyl) acetamides: selective dopamine D 4 receptor agonists. Bioorg Med Chem 12:3471–3483
13. SA Glase HC Akunne LM Georgic TG Heffner RG Mackenzie PJ Manley TA Pugsley LD Wise 1997 Substituted [(4-Phenylpiperazinyl)-methyl]benzamides: Selective Dopamine D 4 Agonists J Med Chem 40 1771 9191952 10.1021/jm970021c 1:CAS:528:DyaK2sXjtFyhurs%3D Glase SA, Akunne HC, Georgic LM, Heffner TG, Mackenzie RG, Manley PJ, Pugsley TA, Wise LD (1997) Substituted [(4-Phenylpiperazinyl)-methyl]benzamides: Selective Dopamine D 4 Agonists. J Med Chem 40:1771
14. R Perrone F Berardi NA Colabufo M Leopoldo V Tortorella 2000 A Structure-Affinity Relationship Study on Derivatives of N-[2-[4-(4-Chlorophenyl) piperazin-1-yl]ethyl]-3-methoxybenzamide, a High-Affinity and Selective D4 Receptor Ligand J Med Chem 43 270 10649982 10.1021/jm991138z 1:CAS:528:DyaK1MXotFGgtb0%3D Perrone R, Berardi F, Colabufo NA, Leopoldo M, Tortorella V (2000) A Structure-Affinity Relationship Study on Derivatives of N-[2-[4-(4-Chlorophenyl) piperazin-1-yl]ethyl]-3-methoxybenzamide, a High-Affinity and Selective D4 Receptor Ligand. J Med Chem 43:270
15. JH Chern 2004 Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors Bioorg Med Chem Lett 14 2519 2525 15109643 10.1016/j.bmcl.2004.02.092 1:CAS:528:DC%2BD2cXjsVKht70%3D Chern JH, et al. (2004) Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorg Med Chem Lett 14:2519–2525
16. Kimura M, et al. (2003a) Synthesis of novel diphenyl piperazine derivatives and their activities as inhibitors of dopamine uptake in the central nervous system. Bio Med Chem 11:1621–1630
17. Kimura M, et al. (2003b) Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine Transporter. Bio Med Chem 11:3953–3963
18. M Kimura 2004 Efficient asymmetric syntheses, determination of absolute configurations and biological activities of 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3-(phenylamino)propyl]-piperazine as a novel potent dopamine uptake inhibotor in the central nervous system Bioorg Med Chem 12 3069 3078 15142566 10.1016/j.bmc.2004.02.041 1:CAS:528:DC%2BD2cXktVKqtLo%3D Kimura M, et al. (2004) Efficient asymmetric syntheses, determination of absolute configurations and biological activities of 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3-(phenylamino)propyl]-piperazine as a novel potent dopamine uptake inhibotor in the central nervous system. Bioorg Med Chem 12:3069–3078
19. CC Guo RB Tong KL Li 2004 Chloroalkyl piperazine and nitrogen mustard porphyrins: Synthesis and anticancer activity Bioorg Med Chem 12 2469 2475 15080942 10.1016/j.bmc.2004.01.045 1:CAS:528:DC%2BD2cXjtVOjs74%3D Guo CC, Tong RB, Li KL (2004) Chloroalkyl piperazine and nitrogen mustard porphyrins: Synthesis and anticancer activity. Bioorg Med Chem 12:2469–2475
20. M Kimara T Masuda K Yamada 2004 Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter Bioorg Med Chem Lett 14 4287 4290 10.1016/j.bmcl.2004.05.091 1:CAS:528:DC%2BD2cXlvVWjtrc%3D Kimara M, Masuda T, Yamada K (2004) Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter. Bioorg Med Chem Lett 14:4287–4290
21. JH Chern 2004 Design, synthesis, and structure–activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors Bioorg Med Chem Lett 14 10 2519 2525 15109643 10.1016/j.bmcl.2004.02.092 1:CAS:528:DC%2BD2cXjsVKht70%3D Chern JH, et al. (2004) Design, synthesis, and structure–activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorg Med Chem Lett 14(10):2519–2525
22. EA Amin WJ Welsh 2003 Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Models for a Novel Class of Piperazine-Based Stromelysin-1 (MMP-3) Inhibitors: Applying a “Divide and Conquer” Strategy J Med Chem 44 3849 3855 10.1021/jm010236t 1:CAS:528:DC%2BD3MXnsV2ksL0%3D Amin EA, Welsh WJ (2003) Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Models for a Novel Class of Piperazine-Based Stromelysin-1 (MMP-3) Inhibitors: Applying a “Divide and Conquer” Strategy. J Med Chem 44:3849–3855
23. S Nanjunda Swamy 2006 Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: Antimicrobial Studies Bioorg Med Chem Lett 16 999 1004 16298529 10.1016/j.bmcl.2005.10.084 1:CAS:528:DC%2BD28Xhs1Kntw%3D%3D Nanjunda Swamy S, et al. (2006) Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: Antimicrobial Studies. Bioorg Med Chem Lett 16:999–1004
24. JN Narendra Sharath Chandra CT Sadashiva CV Kavitha KS Rangappa 2006 Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of-[bis(4-fluorophenyl)-methyl]piperazine Bioorg Med Chem 14 6621 6627 16784863 10.1016/j.bmc.2006.05.064 1:CAS:528:DC%2BD28XosVOiurw%3D Narendra Sharath Chandra JN, Sadashiva CT, Kavitha CV, Rangappa KS (2006) Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of-[bis(4-fluorophenyl)-methyl]piperazine. Bioorg Med Chem 14:6621–6627
25. Priya BS, Anil Kumar C, Nanjunda Swamy S, Basappa, Naveen S, Rangappa KS (2007) 2-(2-(2-Ethoxybenzoylamino)-4-chlorophenoxy)-N-(2-ethoxybenzoyl)benzamine inhibits EAT cell induced angiogenesis by down regulation of VEGF secretion. Bioorg Med Chem Lett 17:2775–2780
26. NR Thimmegowda 2007 Synthesis and Evaluation of Tricyclic Dipyrido Diazepinone Derivatives as Inhibitors of Secretory Phospholipase A2 with Anti-Inflammatory Activity Curr Top Med Chem 7 811 820 17456044 10.2174/156802607780487650 1:CAS:528:DC%2BD2sXlvVGqu70%3D Thimmegowda NR, et al. (2007) Synthesis and Evaluation of Tricyclic Dipyrido Diazepinone Derivatives as Inhibitors of Secretory Phospholipase A2 with Anti-Inflammatory Activity. Curr Top Med Chem 7:811–820
27. JN Narendra Sharath Chandra 2007 Chemistry and Structural Evaluation of Different Phospholipase A2 Inhibitors in Arachidonic Acid Pathway Mediated Inflammation and Snake Venom Toxicity Curr Top Med Chem 7 787 800 17456042 10.2174/156802607780487678 1:STN:280:DC%2BD2s3kslGnug%3D%3D Narendra Sharath Chandra JN, et al. (2007) Chemistry and Structural Evaluation of Different Phospholipase A2 Inhibitors in Arachidonic Acid Pathway Mediated Inflammation and Snake Venom Toxicity. Curr Top Med Chem 7:787–800
28. C Anil Kumar 2007 N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo. J Med Chem 3 269 276 10.2174/157340607780620699 Anil Kumar C, et al. (2007) N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo. J Med Chem 3:269–276
29. Anil Kumar C, et al. (2007) Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells. Invest New Drugs (in press). doi: 10.1007/s10367-006-9033-4
30. XH Zou 2004 Chondroitin Sulfate in Palatal Wound Healing J Dent Res 83 11 880 885 15505240 1:CAS:528:DC%2BD2cXhtVenur3I 10.1177/154405910408301111 Zou XH, (2004) Chondroitin Sulfate in Palatal Wound Healing. J Dent Res 83(11):880–885